MedPath

Petrolatum

Generic Name
Petrolatum
Brand Names
A+d Diaper Rash, Anbesol Cold Sore Therapy, Calazime Skin Protectant, Calmoseptine Ointment, DermaCerin, Flanders, Lubrifresh P.M., Periguard, Preparation H Cream, Preparation H Reformulated Jun 2013, Refresh Lacri-lube, Refresh PM, Resinol, Soothe & Cool Skin Paste, Soothe Night Time, Stye, Systane, Systane Nighttime, Tears Again Ointment, Vusion, Zincofax
Drug Type
Small Molecule
CAS Number
8009-03-8
Unique Ingredient Identifier
B6E5W8RQJ4

Overview

A colloidal system of semisolid hydrocarbons obtained from petroleum. It is used as an ointment base, topical protectant, and lubricant.

Indication

For use as an over the counter skin protectant . Commonly used to treat diaper rash and chapped lips .

Associated Conditions

  • Dermabrasion
  • Diaper Rash
  • Dry Skin
  • Itching of the perianal area
  • Pain
  • Skin Irritation
  • Burning skin sensation
  • Minor burns

Research Report

Published: Sep 25, 2025

A Comprehensive Monograph on Petrolatum (CAS 8009-03-8): From Physicochemical Properties to Clinical and Cosmetic Applications

I. Executive Summary

Petrolatum is a complex, semi-solid mixture of hydrocarbons derived from petroleum, universally recognized for its exceptional occlusive and emollient properties. This monograph provides a comprehensive analysis of Petrolatum, identified by DrugBank ID DB11058 and CAS Number 8009-03-8, covering its chemical identity, manufacturing processes, mechanism of action, therapeutic and cosmetic applications, safety profile, and global regulatory status.

A central theme of this report is the paramount importance of the refining process in determining the quality and safety of the final product. The analysis establishes a clear distinction between highly refined cosmetic and pharmaceutical grades of Petrolatum, which are demonstrably safe for human use, and less-refined industrial grades that may pose health risks due to potential contamination with polycyclic aromatic hydrocarbons (PAHs). The safety, efficacy, and regulatory acceptance of Petrolatum are therefore entirely contingent on its purity.

In the United States, the Food and Drug Administration (FDA) approves Petrolatum as an over-the-counter (OTC) skin protectant, and it serves as a ubiquitous excipient and active ingredient in a vast array of dermatological, ophthalmic, and anorectal preparations. Concurrently, it is a cornerstone ingredient in the global cosmetics and personal care industry.

This report also details a significant paradigm shift in the scientific understanding of Petrolatum. Long considered a chemically inert barrier, recent clinical evidence reveals it possesses bioactive properties, actively modulating the skin's innate immune response and promoting the expression of key epidermal differentiation proteins. This modern understanding provides a molecular basis for its profound efficacy in treating barrier-deficient skin conditions.

Continue reading the full research report

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Jack Black L.L.C.
66738-171
TOPICAL
40.2 g in 100 mL
9/5/2025
MY IMPORTS USA LLC
51628-4248
TOPICAL
53.4 g in 100 g
8/22/2025
Harris Teeter
72036-069
TOPICAL
1 g in 1 g
3/3/2025
FAMILY DOLLAR STORES, INC
55319-952
TOPICAL
410 mg in 1 g
5/27/2025
Jack Black L.L.C.
66738-161
TOPICAL
40.2 g in 100 mL
9/5/2025
Pharmaceutics Corporation
49430-053
TOPICAL
30 mg in 1 1
3/20/2015
REVLON
10967-673
TOPICAL
56.8 mg in 1 g
8/1/2025
MY IMPORTS USA LLC
51628-4249
TOPICAL
100 g in 100 g
8/24/2025
Amazon.com Services LLC
72288-180
TOPICAL
410 mg in 1 g
9/15/2025
Walgreens
0363-0712
TOPICAL
99 g in 100 g
7/13/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
PROTECTIVE OINTMENT
02325578
Ointment - Topical
98.79 % / W/W
6/4/2010
WHITE PETROLEUM JELLY ULTRA MOISTURIZER
belvedere international inc.
02320797
Ointment - Topical
100 %
5/1/2009
FORMULATION R HEMORRHOIDAL OINTMENT
g&w laboratories inc.
02246389
Ointment - Topical
71.9 %
N/A
HEEL BALM
tanta pharmaceuticals inc
02371561
Cream - Topical
9.88 %
N/A
PETROLATUM JELLY UNSCENTED
cellchem pharmaceuticals inc.
02322757
Ointment - Topical
100 % / W/W
N/A
COSMACARE WHITE PETROLATUM OINTMENT USP
cosmaceutical research lab inc.
02368765
Ointment - Topical
100 %
N/A
WHITE PETROLEUM JELLY 100% BP
h.j. sutton industries ltd.
00745790
Ointment - Topical
100 %
12/31/1989
PETROLEUM JELLY SCENTED
02386623
Ointment - Topical
99.6 % / W/W
6/8/2013
MEDICATED LIPBALM
norwood packaging ltd
02286866
Stick - Topical
39.0 %
N/A
NURSING CREAM
e.t. browne drug co., inc.
02239629
Cream - Topical
95.96 %
12/15/1999

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.